LT - COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4.
EN - COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4.
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07K 16/28 |
(2006.01) |
|
|
C07K 16/2818 |
(2013.01) |
|
|
A61K 31/7034 |
(2006.01) |
|
|
A61K2039/505 |
(2013.01) |
|
|
A61K 39/00 |
(2006.01) |
|
|
C07K2317/76 |
(2013.01) |
|
|
A61K 31/7034 |
(2013.01) |
|
|
A61P 35/00 |
(2018.01) |
|
|
A61K 31/197 |
(2013.01) |
|
|
A61K 31/395 |
(2013.01) |
|
|
A61K 31/69 |
(2013.01) |
|
|
A61K 31/702 |
(2013.01) |
|
|
A61K 31/7068 |
(2013.01) |
European patent
| (11) |
Number of the document |
3497131 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
17755592.7 |
|
Date of filing the European patent application |
2017-08-07 |
| (97) |
Date of publication of the European application |
2019-06-19 |
| (45) |
Date of publication and mention of the grant of the patent |
2022-03-09
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/US2017/045690 |
|
Date |
2017-08-07 |
PCT application publication
| (87) |
Number |
WO 2018/031445 |
|
Date |
2018-02-15 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201662372116 P |
2016-08-08
|
US |
|
201662417045 P |
2016-11-03
|
US |
|
201662418722 P |
2016-11-07
|
US |
Inventors
| (72) |
MAGNANI, John L. , US
FOGLER, William E. , US
|
Grantee
| (73) |
GlycoMimetics, Inc. ,
9708 Medical Center Drive, Rockville, MD 20850,
US
|
Title
| (54) |
COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4. |
| |
COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4. |
